COMMUNIQUÉS West-GlobeNewswire

Blueprint for Action Calls for Pan-Canadian Leadership to Close the Women’s Health Gap
05/02/2026
New national plan outlines how Canada can improve women’s health, strengthen participation, and unlock economic gains TORONTO, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Women’s Health Collective Canada (WHCC) today released [...]
Guerbet : 2025 revenue.
05/02/2026
2025 revenue Full-year revenue: €786.4 million, down 3.5% at CER 1 and on a like-for-like basis 2 , largely due to the fall in business in France A decline in Q4 of 5.6% at CER and on a like-for-like basis, linked to [...]
Cross Medical Group Announces New Villanova Office Location
05/02/2026
Move Reflects the Philadelphia Area Practice’s Ongoing Commitment to Patient Care VILLANOVA, Pa., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Cross Medical Group, a cosmetic surgery practice specializing in procedures for the [...]
Novo Nordisk issues statement on illegal mass compounding and deceptive advertising by Hims & Hers
05/02/2026
Bagsværd, Denmark and Plainsboro, NJ, 5 February 2026 – Novo Nordisk today issued the following statement regarding the announcement by Hims & Hers that they will unlawfully mass-market an unapproved, inauthentic, [...]
Virbac : Declaration of the number of shares and voting rights 01/2026
05/02/2026
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial [...]
Guerbet : Chiffre d’affaires 2025.
05/02/2026
Chiffre d’affaires 2025 Chiffre d’affaires annuel : 786,4 M€, soit un repli de 3,5% à TCC 1 et périmètre comparable 2 , largement dû à la baisse de l’activité en France Au quatrième trimestre, une baisse de 5,6% à TCC [...]
Le plan d’action Diriger pour combler l’écart demande aux acteurs au pouvoir partout au pays de réduire les disparités en matière de santé des femmes
05/02/2026
Un nouveau plan national présente comment le Canada peut améliorer la santé des femmes et renforcer leur participation à la société afin de faire de nouveaux gains économiques TORONTO, 05 févr. 2026 (GLOBE NEWSWIRE) -- [...]
GRI Bio to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial
05/02/2026
– Live video webcast on Wednesday, February 11 th at 1:00 PM EST LA JOLLA, CA, Feb. 05, 2026 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative [...]
Serotonin Anti-Aging Center to Open Lake Nona Location This Spring, Expanding Orlando Presence
05/02/2026
New Center Will Be Brand’s Fourth in Orlando and 15th Nationwide ORLANDO, Fla., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Serotonin Anti-Aging Centers , a national leader in science-backed longevity, hormone optimization, and [...]
Phathom Pharmaceuticals to Present at the Guggenheim Emerging Outlook Biotech Summit 2026
05/02/2026
FLORHAM PARK, N.J., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) [...]
Profusa Announces 1-for-75 Reverse Stock Split
05/02/2026
BERKELEY, California, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a commercial stage digital health company pioneering a next-generation technology platform enabling the [...]
Chiesi Global Rare Diseases Reinforces Long-Term Commitment to the Rare Disease Community with Multiple Abstract Presentations at the 22nd Annual WORLDSymposium™
05/02/2026
-- Chiesi’s abstract presentations will focus on clinical insights and patient-reported outcomes in Fabry disease and alpha-mannosidosis -- -- These scientific contributions in lysosomal storage disorders (LSDs) [...]
Longeveron Applauds Passage of the Mikaela Naylon Give Kids a Chance Act and Reauthorization of Rare Pediatric Disease Priority Review Voucher Program
05/02/2026
The Mikaela Naylon Give Kids a Chance Act reauthorizes the Pediatric Priority Review Voucher (PPRV) Program and extends eligibility for medicines achieving U.S. FDA approval before September 2029 The Pediatric Priority [...]
Akari Therapeutics to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial
05/02/2026
– Live video webcast on Tuesday, February 10 th at 1:00 PM EST TAMPA, Fla. and LONDON, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX ), an oncology biotechnology company pioneering next- [...]
Primmune Therapeutics Appoints Chief Medical Officer and Executive Board Chair; Establishes Melanoma Clinical Study Advisory Board
05/02/2026
Leadership additions strengthen clinical excellence and governance as the company enters its next phase of growth SAN DIEGO, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Primmune Therapeutics, Inc. , a biotech company harnessing [...]
Chiesi Global Rare Diseases Reinforces Long-Term Commitment to the Rare Disease Community with Multiple Abstract Presentations at the 22nd Annual WORLDSymposium™
05/02/2026
-- Chiesi’s abstract presentations will focus on clinical insights and patient-reported outcomes in Fabry disease and alpha-mannosidosis -- -- These scientific contributions in lysosomal storage disorders (LSDs) [...]
Alignment Healthcare to Announce Fourth Quarter and Full-Year 2025 Financial Results and Host Conference Call Thursday, Feb. 26, 2026
05/02/2026
ORANGE, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), will release its fourth quarter and full-year 2025 financial results on Thursday, Feb. 26, 2026, after market close. Following [...]
Basic Jane Advances Science-Led Cannabinoid Platform Focused on Senior Care and Scalable Product Formats
05/02/2026
SEATTLE, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Basic Jane, a consumer product–focused subsidiary of Verda Bio, today highlighted its evolution from a mission-driven CBD brand into a scalable, partner-ready cannabinoid [...]
Erasca to Present at Upcoming Conferences in February
05/02/2026
SAN DIEGO, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/ [...]

Pages